Navigation Links
GenScript Announces Joint Road Show with Open Monoclonal Technology, Inc.
Date:1/22/2013

PISCATAWAY, N.J., Jan. 22, 2013 /PRNewswire/ -- GenScript and Open Monoclonal Technology, Inc. (OMT) today announced a joint road show with potential clients across the US, China, Japan and South Korea in late January and early February. The road show will offer prospective clients introductions to GenScript and OMT's human antibody discovery technologies and explore new ways of accelerated and improved development of this important class of human therapeutics.

GenScript

GenScript offers a full spectrum of human antibody services, including target screening and expression, immunization, monoclonal antibody screening at any desired high complexity, antibody sequencing and characterization, biological and other assays, antibody production cell line development, model animal-based efficacy studies and more. GenScript's antibody development team consists of senior scientists and business managers who have extensive experience in therapeutic antibody development. They have been involved in the full process of therapeutic drug development. GenScript has already successfully gained a top position in gene synthesis worldwide, and has established leading positions in many other biology service areas.

Open Monoclonal Technology, Inc.

Open Monoclonal Technology, Inc. (OMT) is a leader in genetic engineering of animals for the development of human therapeutic antibodies – naturally optimized human antibodies™. OMT has created OmniRat™, the first fully human monoclonal antibody platform based on transgenic rats. OmniRat™ uses an improved understanding of B cell development and a new approach to inactivation of endogenous antibody expression, which enables them to make antibodies with human idiotypes as efficiently as wild type rats make normal antibodies. OmniRat™ represents a novel and proprietary technology
'/>"/>

SOURCE GenScript USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. GenScript anuncia un programa conjunto con Open Monoclonal Technology, Inc.
2. GenScript kündigt gemeinsame Roadshow mit Open Monoclonal Technology, Inc. an
3. GenScript anuncia una muestra itinerante conjunta con Open Monoclonal Technology, Inc.
4. GenScript Anuncia Exposição Itinerante Junto com a Open Monoclonal Technology, Inc.
5. TNI BioTech, Inc. Announces Appointment of New CFO
6. NeuroSigma Announces Receipt of Notice of Allowance of U.S. Patent Application Related to External Trigeminal Nerve Stimulation (eTNS) for the Treatment of Neuropsychiatric Disorders
7. BioDelivery Sciences Announces Completion of BNX Safety Study
8. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
9. IRIDEX Announces Preliminary Unaudited Revenues for 2012 Fourth Quarter and Year End
10. Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
11. Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 China Information Technology, Inc. (the "Company" ... integrated cloud-based platform, exchange, and big data solutions in ... Company launched its mobile app for Healthcare One Pass, ... on mobile devices. The Company jointly hosted the launch ... Bureau and Shenzhen News Net.   The mobile ...
(Date:7/5/2015)... July 6, 2015 Nihon University is ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up ... 2015 in Tokyo, Japan . ... applied research will present their achievements and future ... new industry produced with 8K technology. ...
(Date:7/4/2015)... , Spanje, July 4, 2015 ... harsmicrosferen aan eerstelijns chemotherapie voor patiënten met ... (mCRC) verlengt de progressievrije overleving in dat ... gemetastaseerde colorectale kanker (mCRC) die alleen binnen ... gezien in progressievrije overleving (PFS) in de ...
Breaking Medicine Technology:CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5
... 2010 Amicus Therapeutics (Nasdaq: FOLD ), ... diseases, today announced that it has been awarded a ... Parkinson,s Research (MJFF) for the development of a novel, ...  The $500,000 award will be distributed over a period ...
... 2010 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. ... "Company"), which is engaged in the research, development, ... cosmetic products in the People,s Republic of China ... (the "NYSE Amex" or "Exchange") has accepted the ...
Cached Medicine Technology:Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 2Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 3Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 4Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease 5NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 2NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing 3
(Date:7/6/2015)... News, VA (PRWEB) , ... July 06, 2015 ... ... today that Dr. Jeffrey R. Carlson finished his 100th case using SpineFrontier’s® PedFuse® ... Secours Mary Immaculate Hospital in Newport News, VA. The procedure was an L5-S1 ...
(Date:7/6/2015)... ... July 06, 2015 , ... Thanks to donations and a generous grant ... Music & Memory Certification for hospice patients and adult day center participants. , The ... to patients but also to their families and volunteers. Music & Memory is a ...
(Date:7/5/2015)... MN (PRWEB) , ... July 06, 2015 , ... ... the ancillary benefits market, is excited to announce the next generation of PrimeStar ... and Advantage plans to now include two network options—Maximum Allowable Charge (MAC) and ...
(Date:7/5/2015)... ... July 05, 2015 , ... Women's Excellence in Wellness, powered by ... These classes are geared towards families that want their children to stay active as ... The fitness class will take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s ...
(Date:7/5/2015)... , ... July 05, 2015 , ... Women’s Excellence ... college) at their Lake Orion location. The special consists of 2 months of unlimited ... Wellness, powered by Movestrong is located at 1410 South Lapeer Road in Lake Orion. ...
Breaking Medicine News(10 mins):Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:Security Life Insurance Company of America Launches the Next Generation of PrimeStar Individual Dental Insurance Plans 2
... Today the Global AIDS,Alliance Fund responded to the plan ... Dr. Paul Zeitz, Executive Director of the Global ... other experts will discuss the,issue further on a conference ... thrilled to see Senator Clinton,s plan of action on ...
... high-tech identification system,developed in Japan will improve accuracy ... victims of mass disasters, according to a study,presented ... Society of North,America (RSNA)., "Families waiting to ... for the identification process to resolve," said Eiko ...
... dies. It is still not possible to restore the scar ... stem cell researchers attempt to make new heart muscle cells ... Center, however, was able to prove the concept of using ... heart: this cell therapy ensured that less tissue died and ...
... SURGEONS, GREATER ACCESS TO PATIENT DATA AND IMAGES IN THE ... ... ALISO VIEJO, Calif., Nov. 27 Global Care Quest, Inc.,(GCQ), an innovator ... leader in minimally invasive,endoscopic technologies and operating room integration, and GCQ have,expanded ...
... LOS ANGELES, Calif., Nov. 27 Los Angeles, ... Therapy, are joining,forces to create a unique partnership ... cosmetic services., (Photo: http://www.newscom.com/cgi-bin/prnh/20071127/CLTU058 ), ... Laser Hair Therapy, a,safe procedure that assists in ...
... to ... Pharmacopeia, PRINCETON, ... the discovery and development of novel,small molecule therapeutics, announced today that ... with GlaxoSmithKline (NYSE:,GSK), through its collaboration with the Center of Excellence ...
Cached Medicine News:Health News:Senator Clinton's Plan 'The Kind of Leadership We Need on AIDS' 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 2Health News:New Automated System IDs Victims of Mass Disasters in Minutes 3Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 2Health News:KARL STORZ and Global Care Quest Announce Extension of Marketing Agreement 3Health News:Low-level Laser Therapy Clinics' Partnership Targets Helping People Nationwide 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 2Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 3Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 4Health News:Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds 5
Microforceps: Claes ILM Forceps...
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: